Abstract

E Hilton employee of GSK and holds stock options/shares

N Brearley employee of GSK and holds stock options/shares

R Birk employee of GSK and holds stock options/shares

C-Q Zhu employee of GSK and holds stock options/shares

GJ Criner received grants from US NIH and the Department of Defense, consulting from AstraZeneca, Boehringer Ingelheim, Holaira, Mereo, Third Pole, PneumRX, Pulmonx, Pearl, Amirall, CSA Medical, Broncus, AVISA, Lungpacer and GlaxoSmithKline; and contracted clinical trials from AstraZeneca, Avisa, Mereo,Boehringer Ingelheim, Broncus, GlaxoSmithKline, Lungpacer,Novartis, Pulmonx, PneumRx/BTG, and Yungjin

M Dransfield received grants from US NIH and the Department of Defense, consulting from AstraZeneca, Boehringer Ingelheim, Boston Scientific, Genentech, and GlaxoSmithKline; and contracted clinical trials from AstraZeneca, Boehringer Ingelheim, Boston Scientific, GlaxoSmithKline, Novartis, Pulmonx, PneumRx/BTG, and Yungjin

D Halpin received personal fees from GSK; personal fees and non-financial support from AstraZeneca; personal fees and non-financial support from Boehringer Ingelheim; personal fees and non-financial support from Novartis; personal fees from Pfizer; personal fees from Chiesi

DA Lomas received grants, honoraria, and consultancy fees from GSK and chaired the GSK Respiratory Therapy Area Board from 2012–2015

DA Lipson employee of GSK and holds stock options/shares